Apellis Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Apellis Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2020 to Q3 2022.
  • Apellis Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending September 30, 2022 was $124M, a 15.1% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $124M -$22.2M -15.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $248M -$79.9M -24.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $332M -$126M -27.6% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $60.4M -$252M -80.6% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $147M -$166M -53.1% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $328M -$187M -36.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $458M +$229M +100% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $312M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $313M Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $515M Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $229M Mar 31, 2020 10-Q 2020-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.